Companies: 49,246 Total Market Cap: 132430457525715.38

C-Rad AB (publ)

LON-0R44
Electromedical and Electrotherapeutic Apparatus
Rank #23450
Market Cap 110.59 M
Volume 250
Price 40.25
Change (%) 0.00%
Country or region Sweden Sweden

C-Rad AB (publ)'s latest marketcap:

110.59 M

As of 05/20/2025, C-Rad AB (publ)'s market capitalization has reached $110.59 M. According to our data, C-Rad AB (publ) is the 23450th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 110.59 M
Revenue (ttm) 48.44 M
Net Income (ttm) 3.32 M
Shares Out 0
EPS (ttm) 0.10
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 05/07/2025
Market Cap Chart
Data Updated: 05/20/2025

C-Rad AB (publ)'s yearly market capitalization.

C-Rad AB (publ) has seen its market value drop from £145.62 M to £82.71 M since 2020, representing a total decrease of 43.20% and an annual compound decline rate (CAGR) of 12.09%.
Date Market Cap Change (%)
05/20/2025 £82.71 M 13.48%
12/30/2024 £72.88 M -34.12%
12/29/2023 £110.63 M 8.01%
12/30/2022 £102.43 M -33.48%
12/30/2021 £153.99 M 5.75%
12/30/2020 £145.62 M

Company Profile

About C-Rad AB (publ)

C-Rad AB (publ) is a global leader in developing, manufacturing, and selling advanced radiotherapy solutions for cancer treatment. The company operates across Europe, the Middle East, Africa, the Americas, and the Asia Pacific.

Core Products & Solutions

  • Sentinel 4DCT: A laser-based optical surface scanning system for precise radiotherapy.
  • Catalyst+ HD: A patient positioning and motion management solution for conventional and stereotactic treatments.
  • Catalyst+ PT: A surface image-guided radiation therapy system supporting proton therapy.
  • Catalyst+ HD Ring Gantry: Enhances patient positioning and real-time motion monitoring.
  • Catalyst Series: Includes 4D surface-guided radiation therapy (SGRT) solutions for various treatment needs.
  • cAutoVerify & cAccessory: Automation solutions for patient identity validation and accessory tracking.

Additional Offerings

  • SmartPhantom RT & StaticPhantom: Devices for laser alignment and precision verification.
  • High Impact Technology (HIT) Systems: Motorized laser positioning solutions for patient alignment.
  • Support & Training: Comprehensive service contracts and training programs.

Founded in 2004, C-Rad AB (publ) is headquartered in Uppsala, Sweden, and continues to innovate in the field of radiotherapy technology.

Frequently Asked Questions

As of 05/20/2025, C-Rad AB (publ) (including the parent company, if applicable) has an estimated market capitalization of $110.59 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

C-Rad AB (publ) global market capitalization ranking is approximately 23450 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Sweden
Founded 2004
IPO Date n/a
Employees 99
CEO Cecilia de Leeuw
Sector
Industry Electromedical and Electrotherapeutic Apparatus
Address SjukhusvAegen 12K
Uppsala, 753 09
Sweden
Website https://www.c-rad.com
People Also Watch
PHG
23.90 0.00%
KOSDAQ-389650
29.01 0.00%
Vuno
13.20 0.00%
Synthetica AD
41.92 0.00%